The rGel/BLyS fusion toxin specifically targets malignant B cells expressing the BLyS receptors BAFF-R, TACI, and BCMA.

Source:http://linkedlifedata.com/resource/pubmed/id/17267661

Download in:

View as

General Info

PMID
17267661